Gombar C T, Demarinis R M, Wise M, Mico B A
Department of Drug Metabolism, Smith Kline & French Laboratories, King of Prussia, PA 19406-0939.
Drug Metab Dispos. 1988 May-Jun;16(3):367-72.
To aid in the effort to discover novel agents for the treatment of cardiovascular disease, the relationships between pharmacokinetic parameters in the rat and lipophilicity and basicity were studied for a series of 6-chloro-2,3,4,5-tetrahydro-3-substituted-1H-3-benzazepines. Eight compounds, ranging in lipophilicity from log P = 1.64 to 3.50 and basicity from pKa = 6.75 to 9.36, were studied. The compounds were administered iv to rats, and the pharmacokinetic parameters were calculated from the plasma concentration-time curves. Plasma protein binding was determined in vitro using equilibrium dialysis to allow calculation of steady state volume of distribution of unbound drug, Vss,u; and tissue binding. Stepwise regression analysis with each pharmacokinetic parameter as the dependent variable and log P and pKa as the independent variables was performed. In no case was there a significant relationship between a pharmacokinetic parameter and both of the independent variables. Statistically significant linear relationships were found between pKa and Vss and t 1/2z. Lipophilicity was found to correlate with the free fraction in plasma and the free fraction in tissues. The clearance parameters did not correlate with either of the physicochemical parameters. The pharmacokinetics of the one secondary amine in the series were clearly different from those of any of the tertiary amines. The clearance of the secondary amine was lower and the volume of distribution higher than any of the tertiary amines. These results demonstrate that alteration of the lipophilicity of 3-substituted benzazepines does not alter their pharmacokinetics in a predictable fashion but that the pharmacokinetics of secondary amines may be substantially different than tertiary amines.
为助力发现用于治疗心血管疾病的新型药物,针对一系列6-氯-2,3,4,5-四氢-3-取代-1H-3-苯并氮杂䓬,研究了大鼠体内药代动力学参数与亲脂性和碱性之间的关系。研究了8种化合物,其亲脂性范围为log P = 1.64至3.50,碱性范围为pKa = 6.75至9.36。将这些化合物静脉注射给大鼠,并根据血浆浓度-时间曲线计算药代动力学参数。采用平衡透析法体外测定血浆蛋白结合率,以便计算未结合药物的稳态分布容积Vss,u以及组织结合率。以每个药代动力学参数为因变量,log P和pKa为自变量进行逐步回归分析。在任何情况下,药代动力学参数与两个自变量之间均无显著关系。发现pKa与Vss以及t 1/2z之间存在统计学上显著的线性关系。发现亲脂性与血浆中的游离分数以及组织中的游离分数相关。清除率参数与任何一个理化参数均无相关性。该系列中的一种仲胺的药代动力学明显不同于任何叔胺的药代动力学。仲胺的清除率低于任何叔胺,而分布容积高于任何叔胺。这些结果表明,3-取代苯并氮杂䓬亲脂性的改变并不会以可预测的方式改变其药代动力学,但仲胺的药代动力学可能与叔胺有很大不同。